Estimation of tegaserod in human plasma by high-performance liquid chromatography-tandem mass spectroscopy and its application to bioequivalence study

Analytica Chimica Acta

Volumn 557, Issue 1-2, 2006, Pages 229-235

  Singh, Sonu Sundd ^a   Patel, Harshvardhan ^a   Sharma, Kuldeep ^a  

^a ZYDUS RESEARCH CENTRE   (India)

Author keywords

Bioequivalence; Human plasma; Tegaserod; Validation

Indexed keywords

ACETONITRILE; CORRELATION METHODS; DRUG PRODUCTS; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REACTION KINETICS;

BIOEQUIVALENCE; HUMAN PLASMA; TEGASEROD; VALIDATION;

PLASMAS;

ACETONITRILE; ATORVASTATIN; FORMIC ACID; TEGASEROD; WATER;

ADULT; BIOEQUIVALENCE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG STRUCTURE; FOOD AND DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; TABLET; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 30744475236     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2005.10.044     Document Type: Conference Paper

References (6)

1. A. Rivkin Clin. Ther. 25 2003 1952
2. A.E.M. Vickers, M. Zollinger, R. Dannecker, R. Tynes, F. Heitz, and V. Fischer Drug Metabol. Dispos. 29 2001 1269
3. A. Radi Anal. Lett. 37 2004 1103
4. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001 BP, website: http://www.fda.gov/cder/guidance/index.htm.
5. FDA Guidance for Industry, Bioavailability Studies for Orally Administered Drug - Products-General Considerations, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2000, website: http://www.fda.gov/cder/guidance/index.htm.
6. FDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001, website: http://www.fda.gov/cder/guidance/index.htm.